Kamyar Kalantar-Zadeh M.D. to Recombinant Proteins
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Recombinant Proteins.
Connection Strength
0.588
-
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology. Am J Nephrol. 2017; 45(3):235-247.
Score: 0.135
-
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis. 2008 Oct; 52(4):727-36.
Score: 0.075
-
Epoetin dosing and dialysis facility ownership. JAMA. 2007 Aug 22; 298(8):862; author reply 862-3.
Score: 0.070
-
Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients? Nephrol News Issues. 2007 Jan; 21(1):34-8.
Score: 0.067
-
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006 Apr; 17(4):1181-91.
Score: 0.064
-
A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004 Apr; 43(4):671-84.
Score: 0.055
-
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov; 42(5):864-81.
Score: 0.054
-
Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003 Oct; 42(4):761-73.
Score: 0.053
-
Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment. Semin Dial. 2004 Sep-Oct; 17(5):336-41.
Score: 0.014